Incannex Healthcare Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
IXHL$2.01-8.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
| Common Stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit) | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Amount | Amount | Amount | Amount | |
| # | $ | $ | $ | $ | $ | |
| Balance at June 30, 2025 | 6,479,333 | 20 | 174,049 | (157,556) | (3,124) | 13,389 |
| Stock-based compensation | - | - | 2,626 | - | - | 2,626 |
| Share issuance | 5,110,850 | 15 | 69,450 | - | - | 69,465 |
| Share issuance costs | - | - | (2,288) | - | - | (2,288) |
| Net loss | - | - | - | (6,407) | - | (6,407) |
| Currency translation adjustment, net of tax | - | - | - | - | 223 | 223 |
| Balance at September 30, 2025 | 11,590,183 | 35 | 243,837 | (163,963) | (2,901) | 77,008 |
| Stock-based compensation | - | - | 2,279 | - | - | 2,279 |
| Share issuance | 487,246 | 1 | 2,196 | - | - | 2,197 |
| Share repurchase | (103,466) | - | (1,179) | - | - | (1,179) |
| Share issuance costs | - | - | (91) | - | - | (91) |
| Net loss | - | - | - | (6,521) | - | (6,521) |
| Currency translation adjustment, net of tax | - | - | - | - | (287) | (287) |
| Balance at December 31, 2025 | 11,973,963 | 36 | 247,042 | (170,484) | (3,188) | 73,406 |
| Stock-based compensation | - | - | 1,468 | - | - | 1,468 |
| Share issuance | 1,997,285 | 6 | 6,667 | - | - | 6,673 |
| Share repurchase | (290,561) | (1) | (1,138) | - | - | (1,139) |
| Share issuance costs | - | - | (823) | - | - | (823) |
| Fractional adjustment | 2,434 | |||||
| Net loss | - | - | - | (3,883) | - | (3,883) |
| Currency translation adjustment, net of tax | - | - | - | - | (468) | (468) |
| Balance at March 31, 2026 | 13,683,121 | 41 | 253,216 | (174,367) | (3,656) | 75,234 |
| Common Stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit) | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Amount | Amount | Amount | Amount | |
| # | $ | $ | $ | $ | $ | |
| Balance at June 30, 2024 | 588,094 | 2 | 125,218 | (110,671) | (3,332) | 11,217 |
| Stock-based compensation | - | - | 459 | - | - | 459 |
| Share issuance | - | - | - | - | - | - |
| Net loss | - | - | - | (5,420) | - | (5,420) |
| Currency translation adjustment, net of tax | - | - | - | - | 339 | 339 |
| Balance at September 30, 2024 | 588,094 | 2 | 125,677 | (116,091) | (2,993) | 6,595 |
| Stock-based compensation | - | - | 435 | - | - | 435 |
| Share issuance | 4,747 | - | 242 | - | - | 242 |
| Net loss | - | - | - | (5,894) | - | (5,894) |
| Currency translation adjustment, net of tax | - | - | - | - | (414) | (414) |
| Balance at December 31, 2024 | 592,841 | 2 | 126,354 | (121,985) | (3,407) | 964 |
| Stock-based compensation | - | - | 416 | - | - | 416 |
| Convertible note conversion | 2,138 | - | 100 | - | - | 100 |
| Share issuance | 323,246 | - | 10,726 | - | - | 10,726 |
| Share issuance costs | - | - | (747) | - | - | (747) |
| Net loss | - | - | - | (3,968) | - | (3,968) |
| Currency translation adjustment, net of tax | - | - | - | - | (88) | (88) |
| Balance at March 31, 2025 | 918,225 | 2 | 136,849 | (125,953) | (3,495) | 7,403 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.